Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure

  • Muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced heart failure
  • Adrian Gwizdala, Natalia Rozwadowska, Tomasz Jan Kolanowski, Agnieszka Malcher, Aleksandra Cieplucha, Bartlomiej Perek, Wojciech Seniuk, Ewa Straburzynska-Migaj, Zofia Oko-Sarnowska, Witold Cholewinski, Michal Michalak, Stefan Grajek, Maciej Kurpisz
  • European Journal of Heart Failure, January 2017, Wiley
  • DOI: 10.1002/ejhf.700

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/ejhf.700

In partnership with: